Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2006, has approved the following: The Board has taken note of the order from the High Court of Judicature at Madras for convening of an Extraordinary General Meeting to be held November 27, 2006 for approval of the Scheme of Amalgamation of May (India) Laboratories Pvt Ltd with the Company. Trading members of the Exchange are hereby informed that the under mentioned new securities of Caplin Point Laboratories Limited (Scrip Code: 524742, ISIN No. INE475E01018) are listed and permitted for trading on the Exchange with effect from Wednesday, May 09, 2008. Securities 79,20,000 * Equity Shares of Rs.10/- each issued to the shareholders of erstwhile May (India) Laboratories Private Limited pursuant to the scheme of Amalgamation of the Company. Dist. Nos. 5090001 to 13010000 * These shares are ranking pari-passu with the existing equity shares of the company. 2. Trading members may please note that 94,17,433 equity shares are under lock-in up to May 09, 2011 as per details given below: Number of Securities Distinctive No. 14,97,433Refer Annexure I 79,20,000 5090001 - 13010000 3. The brief particulars of the Scheme of Amalgamation are as mentioned below: a. The Scheme of Amalgamation of the company was approved by the Hon'ble High Court of Judicature at Madras vide its Order dated January 25, 2007. b. Appointed Date: April 01, 2006. c. Effective Date: April 01, 2006. d. Date of Allotment: February 02, 2007. e. Exchange Ratio: For every 8 equity shares of Rs.10/- each held in May (India) Laboratories Private Limited, 1 equity share of Rs.10/- each of the company have been issued. 4. The company's financial year ends on 31st March. (As Per BSE Notice Dated on 08.05.2008)